The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers.
iShares Neuroscience and Healthcare ETF IBRN
Morningstar’s Analysis IBRN
Will IBRN outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 41.2
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Biohaven Ltd | 5.08 | 190,540 | Healthcare |
PTC Therapeutics Inc | 4.41 | 165,470 | Healthcare |
Alkermes PLC | 4.14 | 155,394 | Healthcare |
Dyne Therapeutics Inc Ordinary Shares | 4.06 | 152,353 | Healthcare |
Xenon Pharmaceuticals Inc | 4.05 | 151,950 | Healthcare |
Catalyst Pharmaceuticals Inc | 3.94 | 147,667 | Healthcare |
SK Biopharmaceuticals Co Ltd Ordinary Shares | 3.92 | 146,810 | Healthcare |
argenx SE ADR | 3.90 | 146,124 | Healthcare |
Axonics Inc | 3.90 | 146,039 | Healthcare |
Intra-Cellular Therapies Inc | 3.82 | 143,048 | Healthcare |